Education
What Is Retatrutide?
An overview of the triple-agonist research peptide, its discovery, and why it has become one of the most-studied molecules in metabolic research.
Retatrutide is a synthetic peptide engineered to act on three receptor pathways simultaneously — GLP-1, GIP, and glucagon. This article outlines what makes the molecule structurally distinct, why researchers are paying attention, and how identity and purity are confirmed for laboratory-grade material.
A new shape in metabolic research
Where earlier research peptides targeted single receptors, retatrutide's triple-agonist profile invites different experimental designs. Researchers can probe overlapping signaling cascades without juggling multiple compounds.
Why purity matters
A research peptide is only as useful as its purity. REPRIME tests every batch using HPLC and publishes the COA so any laboratory can verify identity before reconstitution.